LLumiris
Lumiris (legally Lumiris Spectral Solutions SL) is a Barcelona-based medtech spin-off from the Institute for Bioengineering of Catalonia (IBEC) that combines hyperspectral imaging with AI to read the metabolic profile (NADH/FADH) of live embryos and oocytes non-invasively, helping IVF clinics select the embryo with the highest implantation potential. It is a deeptech healthtech/fertility company founded in 2023, based at Parc Científic de Barcelona, and has raised roughly €6M in total including ~€3M in non-dilutive public grants and a €1.5M round in 2024-2025 that combined private IVF-sector investors with a Capital Cell crowdfunding campaign.
SectorsHealthtech, Fertility / Reproductive Medicine, Medical Devices, AI, Hyperspectral Imaging, Deeptech
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
A
Anna Seriola Petit
Co-CEO & Co-founder
J
Jorge Fuentes
Strategy Partner & Co-founder
S
Samuel Ojosnegros Martos
Chief Scientific Officer & Co-founder
Global models 5
AAIVF
Israel · aivf.co ↗
Sells AI software for embryo evaluation and selection to IVF clinics to raise implantation rates.
$25MComparable
FFairtility
Israel · fairtility.com ↗
Its CHLOE AI platform analyses embryo images non-invasively to help IVF clinics pick the embryo most likely to implant.
$25MComparable
AAlife Health
United States · www.alifehealth.com ↗
Sells AI decision-support tools, including embryo assessment, to IVF clinics to improve embryo selection and outcomes.
$16MComparable
P
Presagen
Australia · www.presagen.com ↗
Life Whisperer uses AI on embryo images to score viability for IVF clinics without invasive testing.
$10MComparable
FFuture Fertility
Canada · www.futurefertility.com ↗
Sells AI analysis of oocyte images to fertility clinics to predict egg quality and IVF success without touching the cells.
$9MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 3
Open as list →
Funding rounds 2
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-08-12 | Seed (estimated) | — |
Lead not disclosed
+1 more
|
| 2024-12-18 | Seed (estimated) | €1.5M |
Lead not disclosed
+1 more
|
News
No coverage on record yet.